Federal Priorities

MTC engages policymakers on the local, state and federal levels.  What happens in Congress impacts the technology and life science industries, which means it is important to engage the Maryland Congressional Delegation and other policymakers on important issues.  MTC does this with the guidance and partnership of a variety of organizations including the Biotechnology Industry Organization (MTC is BIO’s Maryland affiliate), the Pharmaceutical Research and Manufacturers of America, We Work for Health, the Advanced Medical Device Technology Association, TechAmerica and the Technology Councils of North America.  Through this coordinated approach, MTC brings value to its members by influencing important issues that impact the bottom line of technology and life science companies.  MTC’s priorities on critical issues include:

  • Support Medicare payment reform that benefits patients and creates an environment where innovative companies can develop new technologies.
  • Support the Prescription Drug User Fee Act (PDUFA) that enhance the drug development and review process.
  • Oppose taxation of medical devices.
  • Support a strong Small Business Investment Research Program (SBIR) and Small Business Technology Transfer (STTR), which support scientific innovation and research that has a focus on commercialization.
  • Increase appropriations for the National Institutes of Health that fund critical research and development contributing to advancement of better health for all Americans.
  • Increase appropriations for the Food and Drug Administration that allows the agency to keep pace with biomedical advancements and furthers medical product development.
  • Oppose changes to Medicare Part D and Part B, which can negatively impact patients and increases cost to the federal government
  • Support efforts to modernize the drug discovery, development, and FDA approval process to advance the discovery of new treatments and cures.
  • Strengthen and create certainty for the federal Research and Development Tax Credit that keeps valuable R&D in the United States and promotes job creation.
  • Repeal the Independent Payment Advisory Board (IPAB), which restricts patients’ access to needed treatments.
  • Invest in education and a highly skilled workforce with a focus on science, technology, engineering and math disciplines at all levels.
  • Create a competitive tax code that balances important needs with the promotion of an innovative and entrepreneurial economy.
  • Invest in America’s transportation, broadband and power infrastructure to meet the needs of tomorrow’s economy.
  • Invest in basic research that seed new discoveries and can be commercialized to create new technologies and jobs.